tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate, 97%, 50mg

5-(4-Chloro-2-methylphenyl)-5-oxovaleric acid, 97.0%, 1g

5-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

1-Benzyl-1,4-diazepane, 98.0%, 25g

(2-Chloro-6-(trifluoromethyl)pyridin-3-yl)boronic acid, 95.0%, 5g

2-(Cyclopentyloxy)ethanol, 95.0%, 250mg

5-((tert-Butoxycarbonyl)amino)pyrazine-2-carboxylic acid, 95.0%, 5g

4-(5-Fluoro-pyrimidin-2-yl)-piperazine-1,3-dicarboxylic acid 1-tert-butyl ester, 1g

6-Bromo-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one, 97%, 500mg

4-Chloro-3-nitrobenzene-1-sulfonyl chloride, 95.0%, 1g

(S)-(+)-2-Butanol, 97.0%, 1g

N-Hydroxysuccinimide, min. 99%, for synthesis, 500 g, glass packaging